Trial Profile
Clinical Trials Insight: 700009518
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2005
Price :
$35
*
At a glance
- Drugs Histamine dihydrochloride (Primary) ; Interleukin-2
- Indications Malignant melanoma
- Focus Adverse reactions
- 30 Nov 2005 New trial record.